References
- Bell JS, Koffie RM, Rattani A, Dewan MC, Baticulon RE, Qureshi MM, Wahjoepramono EJ, Rosseau G, Park K, Nahed BV. Global incidence of brain and spinal tumours by geographic region and income level based on cancer registry data. J ClinNeurosci. 2019 Aug; 66:121-127. doi: 10.1016/j.jocn.2019.05.003. Epub 2019 May 24.
- Fan Y, Zhang X, Gao C, Jiang S, Wu H, Liu Z, Dou T. Burden and trends of brain and central nervous system cancer from 1990 to 2019 at the global, regional, and country levels. Arch Public Health. 2022 Sep 17;80(1):209. doi: 10.1186/s13690-022-00965-5.
- Salari N, Ghasemi H, Fatahian R, Mansouri K, Dokaneheifard S, Shiri MH, Hemmati M, Mohammadi M. The global prevalence of primary central nervous system tumours: a systematic review and meta-analysis. Eur J Med Res. 2023 Jan 20;28(1):39. doi: 10.1186/s40001-023-01011-y. PMID: 36670466.
- WHO Classification of Tumours Editorial Board. Central nervous system tumours. Lyon (France): International Agency for Research on cancer; 2016.
- Tamimi AF, Juweid M. Epidemiology and Outcome of Glioblastoma. In: De Vleeschouwer S, editor. Glioblastoma [Internet]. Brisbane (AU): Codon Publications; 2017 Sep 27. Chapter 8.
- Pouchieu C, Baldi I, Gruber A, Berteaud E, Carles C, Loiseau H. Descriptive epidemiology and risk factors of primary central nervous system tumours: Current knowledge. Rev Neurol (Paris). 2016 Jan;172(1):46-55. doi: 10.1016/j. neurol.2015.10.007. Epub 2015 Dec 23.
- Owonikoko TK, Arbiser J, Zelnak A, et al. Current approaches to the treatment of meta-static brain tumours. Nat Rev Clin Oncol. 2014 Apr;11(4):203—22. PMID:2456944B.